EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells

Shirin Nkongolo, Deeqa Mahamed, Adrian Kuipery, Juan D Sanchez Vasquez, Samuel C Kim, Aman Mehrotra, Anjali Patel, Christine Hu, Ian McGilvray, Jordan J Feld, Scott Fung, Diana Chen und 4 weitere

Journal of Clinical Investigation · 03.01.2023 · 133 (1)

DOI: 10.1172/jci158903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.01.2023. Verfasst von Shirin Nkongolo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Toronto Centre for Liver Disease, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Hepatitis B, Chronic. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicHumansCD8-Positive T-LymphocytesLiver CirrhosisAntiviral AgentsHepatitis B virus

Stichwörter der Autor:innen

Cellular immune responseHepatitisImmunologyInfectious diseaseT cells

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Toronto Centre for Liver Disease, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Gilead Sciences, Foster City, California, USA.
  • Multi-Organ Transplant Program, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.

Förderung

  • Gilead Sciences
  • German Research Foundation

Zitieren

APA

Nkongolo, S., Mahamed, D., Kuipery, A., Sanchez Vasquez, J. D., Kim, S. C., Mehrotra, A., Patel, A., Hu, C., McGilvray, I., Feld, J. J., Fung, S., Chen, D., Wallin, J. J., Gaggar, A., Janssen, H., & Gehring, A. J. (2023). Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells. Journal of Clinical Investigation, 133(1). https://doi.org/10.1172/jci158903

Vancouver

Nkongolo S, Mahamed D, Kuipery A, Sanchez Vasquez JD, Kim SC, Mehrotra A, et al. Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells. Journal of Clinical Investigation. 2023;133(1). doi:10.1172/jci158903

BibTeX
@article{Nkongolo2023,
  author = {Nkongolo, Shirin and Mahamed, Deeqa and Kuipery, Adrian and Sanchez Vasquez, Juan D and Kim, Samuel C and Mehrotra, Aman and Patel, Anjali and Hu, Christine and McGilvray, Ian and Feld, Jordan J and Fung, Scott and Chen, Diana and Wallin, Jeffrey J and Gaggar, Anuj and Janssen, Harry LA and Gehring, Adam J},
  title = {Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  volume = {133},
  number = {1},
  doi = {10.1172/jci158903}
}
Kostenlos starten →